AxSpA is a challenging disease, with a significant impact on the patient’s quality of life – principally in mobility. Existing monitoring requires a mobility assessment by a clinical professional, which can be both intrusive and infrequent. The proliferation of smart devices, such as watches and so-called ‘earables’ in smart headphones, provides a rich amount of data. An AI-based approach will be able to use this data to effectively monitor patient mobility, and thereby disease activity and progression. This will subsequently allow for much more personalised care, and better health outcomes.
AI-enabled healthcare, wearables, bioinformatics, rheumatology.
I graduated in 2016 from the University of Manchester with a MPhys. I then joined the British Army and spent 6 years as an Engineering Officer, going on to specialise in aviation and working with Attack Helicopters. I am accredited as an Incorporated Engineer and as a Chartered Manager, and will also soon graduate with an MSc in Leadership and Conflict Studies from the University of Reading.
Dr Christopher Clarke
